Armistice Capital’s Lexaria Bioscience Warrant LEXXW Stock Holding History

Armistice Capital’s Portfolio LEXXW Stock Details LEXXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-361,905	Closed	-$908K	–	150
2021 Q2	$908K	Hold	361,905	–	–	0.02%	107
2021 Q1	$865K	Buy	+361,905	New	+$794K	0.02%	103

Other funds holding LEXXW

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Armistice Capital's LEXXW Position: Q3 2021 in Review

Armistice Capital sold out of Lexaria Bioscience Warrant (LEXXW) in Q3 2021, closing a stake of 361,905 shares — an estimated $908K sold.

Armistice Capital first reported a position in LEXXW in Q1 2021 and held it in 2 quarters. The position peaked at $908K in Q2 2021. 3 funds tracked by Wall St. Rank hold LEXXW as of Q3 2021.

Armistice Capital reported no remaining Lexaria Bioscience Warrant position as of Q3 2021 after selling out during the quarter.
Armistice Capital sold 361,905 Lexaria Bioscience Warrant shares in Q3 2021, an estimated $908K.
Armistice Capital first reported a position in Lexaria Bioscience Warrant in Q1 2021 and held it in 2 quarters.
Armistice Capital's Lexaria Bioscience Warrant position peaked at $908K in Q2 2021.
3 funds tracked by Wall St. Rank held Lexaria Bioscience Warrant as of Q3 2021.

Based on Armistice Capital's 13F filing for Q3 2021, filed 15 Nov 2021.